This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bajjalieh, S.M. (1999). Synaptic vesicle docking and fusion. Curr. Opin. Neurobiol. 9, 321.
Bennett, M.K. and R.H. Scheller (1993). The molecular machinery for secretion is conserved from yeast to neurons. Proc. Natl. Acad. Sci. USA 90, 2559.
Berk, M., H. Plein, and B. Belsham (2000). The specificity of platelet glutamate receptor supersensitivity in psychotic disorders. Life Sci. 66, 2427.
Bhangu, P.S., P.G. Genever, G.J. Spencer, T.S. Grewal, and T.M. Skerry (2001). Evidence for targeted vesicular glutamate exocytosis in osteoblasts. Bone 29, 16.
Boudignon-Proudhon, C., P.M. Patel, and L.V. Parise (1996). Phorbol ester enhances integrin alpha IIb beta 3-dependent adhesion of human erythroleukemic cells to activation-dependent monoclonal antibodies. Blood 87, 968.
Bruno, E. and R. Hoffman (1998). Human megakaryocyte progenitor cells. Semin. Hematol. 35, 183.
Chenu, C., C.M. Serre, C. Raynal, B. Burt-Pichat and P.D. Delmas (1998). Glutamate receptors are expressed by bone cells and are involved in bone resportion. Bone 22, 295.
Chenu, C., C. Itzstein, and L. Espinosa (2001). Absence of evidence is not evidence of absence: Redundancy blocks determination of cause and effect. J. Bone Miner. Res. 16, 1278.
Das, I., N.S. Khan, B.K. Puri, S.R. Sooranna, J. de Belleroche, and S.R. Hirsch (1995). Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem. Biophys. Res. Commun. 212, 375.
Dobson, K.R. and T.M. Skerry (2000). The NMDA-type glutamate receptor antgonist MK-801 regulates differentiation of rat bone marrow osteoprogenitors and influences adipogenesis. J. Bone Miner. Res. 15, S1, SA211.
Espinosa, L., C. Itzstein, H. Cheynel, P.D. Delmas, and C. Chenu (1999). Active NMDA glutamate receptors are expressed by mammalian osteoclasts. J. Physiol. 518, 47.
Franconi, F., M. Miceli, M.G. De Montis, E.L. Crisafi, F. Bennardini, and A. Tagliamonte (1996). NMDA receptors play an anti-aggregating role in human platelets. Thromb. Haemost. 76, 84.
Franconi, F., M. Miceli, L. Alberti, G. Seghieri, M.G. De Montis, and A. Tagliamonte (1998). Further insights into the anti-aggregating activity of NMDA in human platelets. Br. J. Pharmacol. 124, 35.
Genever, P.G., D.J. Wilkinson, A.J. Patton, N.M. Peet, Y. Hong, and A. Mathur et al. (1999). Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. Blood 93, 2876.
Genever, P.G. and T.M. Skerry (2001). Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: Evidence for intrinsic glutamatergic signaling in bone. FASEB J. 15, 1586.
Gray, C., H. Marie, M. Arora, K. Tanaka, A. Boyde, and S. Jones (2001). Glutamate does not play a major role in controlling bone growth. J. Bone Miner. Res. 16, 742.
Gu, Y. and S.J. Publicover (2000). Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts, Cross-talk with N-methyl-D-aspartate receptors. J. Biol. Chem. 275, 34252.
Hinoi, E., S. Fujimori, Y. Nakamura, and Y. Yoneda (2001). Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. Biochem. Biophys. Res. Commun. 281, 341.
Hinoi, E., S. Fujimori, T. Takarada, H. Taniura, and Y. Yoneda (2002). Facilitation of glutamate release by ionotropic glutamate receptors in osteoblasts. Biochem. Biophys. Res. Commun. 297, 452.
Hinoi, E., S. Fujimori, and Y. Yoneda (2003). Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J. 17, 1532.
Hitchcock, I.S., T.M. Skerry, M.R. Howard, and P.G. Genever (2003). NMDA receptor-mediated regulation of human megakaryocytopoiesis. Blood 102, 1254.
Huggett, J., A. Vaughan-Thomas, and D. Mason (2000). The open reading frame of the Na(+)-dependent glutamate transporter GLAST-1 is expressed in bone and a splice variant of this molecule is expressed in bone and brain. FEBS Lett. 485, 13.
Italiano, J.E., Jr., P. Lecine, R.A. Shivdasani, and J.H. Hartwig (1999). Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J. Cell Biol. 147, 1299.
Itzstein, C., L. Espinosa, P.D. Delmas, and C. Chenu (2000). Specific antagonists of NMDA receptors prevent osteoclast sealing zone formation required for bone resporption. Biochem. Biophys. Res. Commun. 268, 201.
Itzstein, C., H. Cheynel, B. Burt-Pichat, B. Merle, L. Espinosa, P.D. Delmas et al. (2001). Molecular identification of NMDA glutamate receptors expressed in bone cells. J. Cell Biochem. 82, 134.
Laketic-Ljubojevic, I., L.J. Suva, F.J. Maathuis, D. Sanders and T.M. Skerry (1999). Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 25, 631.
Manolagas, S.C. (2000). Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115.
Mason, D.J., L.J. Suva, P.G. Genever, A.J. Patton, S. Steuckle, R.A. Hillam et al. (1997). Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents? Bone 20, 199.
Merle, B., C. Itzstein, P.D. Delmas, and C. Chenu (2003). NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis. J. Cell Biochem. 90, 424.
Olkku, A., P.V. Bodine, A. Linnala-Kankkunen, and A. Mahonen (2004). Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone. Bone 34, 320.
Patton, A.J., P.G. Genever, M.A. Birch, L.J. Suva, and T.M. Skerry (1998). Expression of an N-methyl-D-aspartatetype receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone 22, 645.
Peet, N.M., P.S. Grabowski, I. Laketic-Ljubojevic, and T.M. Skerry (1999). The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J. 13, 2179.
Rodan, G.A. and T.J. Martin (2000). Therapeutic approaches to bone diseases. Science 289, 1508–1514.
Serre, C.M., D. Farley, P.D. Delmas, and C. Chenu (1999). Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 25, 623.
Skerry, T.M., P.G. Genever, A.F. Taylor, K. Dobson, D. Mason, and L.J. Suva (2001). Absence of evidence is not evidence of absence: The shortcomings of the GLAST knockout mouse. J. Bone Miner. Res. 16, 1729.
Spencer, G.J. and P.G. Genever (2003). Long-term potentiation in bone—a role for glutamate in strain-induced cellular memory? BMC Cell Biology 4, 8.
Storck, T., S. Schulte, K. Hofmann, and W. Stoffel (1992). Structure, expression, and functional analysis of a Na(+)-dependent glutamate/asparate transporter from rat brain. Proc. Natl. Acad. Sci. USA 89, 10955.
Takeuchi, K., M. Ogura, H. Saito, M. Satoh, and M. Takeuchi (1991). Production of platelet-like particles by a human megakaryoblastic leukemia cell line (MEG-01). Exp. Cell Res. 193, 223.
Tohyama, Y., K. Tohyama, M. Tsubokawa, M. Asahi, Y. Yoshida, and H. Yamamura (1998). Outside-In signaling of soluble and solid-phase fibrinogen through integrin alphallbbeta3 is different and cooperative with each other in a megakaryoblastic leukemia cell line, CMK. Blood 92, 1277.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Kluwer Academic / Plenum Publishers, New York
About this chapter
Cite this chapter
Spencer, G.J., Hitchcock, I.S., Genever, P.G. (2005). Glutamate: Teaching Old Bones New Tricks—Implications for Skeletal Biology. In: Gill, S., Pulido, O. (eds) Glutamate Receptors in Peripheral Tissue: Excitatory Transmission Outside the CNS. Springer, Boston, MA. https://doi.org/10.1007/0-306-48644-X_12
Download citation
DOI: https://doi.org/10.1007/0-306-48644-X_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47973-1
Online ISBN: 978-0-306-48644-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)